No “DEATH PANELS” – YET -.. just more denial of medication coverage (Updated)
Pharmacy benefit managers, or PBMs, which administer drug benefits for employers and health plans and also run large mail-order pharmacies, have been challenging the rising cost of new medications. When drugs are knocked off their formularies, patients may have to pay full price for them. PBMs often keep or dump a product depending on whether they can obtain favorable pricing…
Here is the full list of drugs dropped by CVS, according to CNN:
Abilify (antipsychotic)
Amitiza (irritable bowel disease)
Avonex (multiple sclerosis)
Bydureon (diabetes)
Carac (dermatology)
Cardizem (high blood pressure)
Clobetasol spray (dermatology)
Clobex spray (dermatology)
Cymbalta (depression)
Diovan (high blood pressure)
Exforge, including Exforge HCT (high blood pressure)
Extavia (multiple sclerosis)
Fluorouracil cream 0.5% (dermatology)
Fortesta (testosterone replacement)
Fosrenol (kidney disease)
Incruse Ellipta (Chronic obstructive pulmonary disease)
Intuniv (ADHD)
Invokameet (diabetes)
Invokana (diabetes)
Matzim LA (high blood pressure)
Monovisc (monovisc)
Noritate (dermatology)
Plegridy (multiple sclerosis)
Qsymia (anti-obesity)
Relistor (gastrointestinal)
Valcyte (anti-infective)
Viagra (erectile dysfunction)
Zubsolv (opioid dependence)
All Things Chronic 
Omg……cardizem? Wtf??
LikeLiked by 1 person
I gather this is just brand names and not their generics.
LikeLiked by 1 person
Nothing is safe. Some generics now cost more than the original brand name. Thankfully I still have freedom of choice. This is a case of SUITS and not DOCTOR’S deciding what is best for their patients. Pharmacy benefit managers care about nothing other than the bottom line!
LikeLiked by 1 person